Vanguard Group’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$155M Buy
1,189,069
+18,647
+2% +$2.56M ﹤0.01% 1672
2025
Q3
$126M Sell
1,170,422
-10,501
-0.9% -$1.14M ﹤0.01% 1753
2025
Q2
$109M Buy
1,180,923
+149,597
+15% +$11.7M ﹤0.01% 1796
2025
Q1
$91.3M Buy
1,031,326
+25,116
+2% +$2.18M ﹤0.01% 1833
2024
Q4
$77.3M Buy
1,006,210
+156,768
+18% +$11M ﹤0.01% 1973
2024
Q3
$36.1M Buy
849,442
+61,241
+8% +$2.07M ﹤0.01% 2319
2024
Q2
$20.6M Buy
788,201
+80,589
+11% +$1.53M ﹤0.01% 2557
2024
Q1
$6.46M Buy
707,612
+28,678
+4% +$172K ﹤0.01% 3187
2023
Q4
$1.87M Sell
678,934
-3
-0% -$7 ﹤0.01% 3626
2023
Q3
$2.47M Buy
678,937
+4
+0% +$22 ﹤0.01% 3512
2023
Q2
$4.05M Sell
678,933
-44,245
-6% -$350K ﹤0.01% 3405
2023
Q1
$8.71M Buy
723,178
+440,204
+156% +$5.87M ﹤0.01% 3008
2022
Q4
$2.46M Buy
282,974
+950
+0.3% +$20.9K ﹤0.01% 3590
2022
Q3
$8.17M Buy
282,024
+1,347
+0.5% +$61.7K ﹤0.01% 3056
2022
Q2
$11.7M Buy
280,677
+113,455
+68% +$7.7M ﹤0.01% 2908
2022
Q1
$16.9M Buy
167,222
+67,470
+68% +$7.5M ﹤0.01% 2864
2021
Q4
$14.7M Buy
99,752
+8,192
+9% +$1.83M ﹤0.01% 3010
2021
Q3
$22.9M Buy
+91,560
New +$31.4M ﹤0.01% 2789

Other funds holding WGS

Vanguard Group's WGS Position: Q4 2025 in Review

Vanguard Group increased its GeneDx Holdings (WGS) stake by 1.6% in Q4 2025, buying an estimated $2.56M and bringing the position to 1,189,069 shares worth $155M. The position accounts for ﹤0.01% of the portfolio, ranked #1672.

Vanguard Group first reported a position in WGS in Q3 2021 and has held it in 18 quarters since. 286 funds tracked by Wall St. Rank hold WGS as of Q4 2025.

  • Vanguard Group held 1,189,069 shares of GeneDx Holdings worth $155M as of Q4 2025.
  • Vanguard Group bought 18,647 GeneDx Holdings shares in Q4 2025, an estimated $2.56M.
  • GeneDx Holdings made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #1672 holding.
  • Vanguard Group first reported a position in GeneDx Holdings in Q3 2021 and has held it in 18 quarters since.
  • 286 funds tracked by Wall St. Rank held GeneDx Holdings as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.